TRIBVN, the European leading provider of medical imaging solutions for laboratory, announced today that its two Digital Pathology software solutions CaloPix and TeleSlide have obtained a Health Canada Class II Medical Device License.
CaloPix and TeleSlide are software solutions for managing, viewing, analyzing and sharing all the images produced in the laboratory. They are effective tools for the implementation of digital pathology within the pathology department, but also among health professionals as part of networks of expertise and second opinion. Homologations of the two products ensure healthcare professionals that TRIBVN software solutions are medical devices developed according to Health Canada guidelines.
Jean-François Pomerol, Director of TRIBVN said: “The approval of TRIBVN software by Health Canada is a key step in addressing the Canadian market. It reflects the wish of TRIBVN to accompany the health professionals of this vast country towards the mutation of the pathology department, which includes the progressive adoption of the screen as the daily support for the diagnosis”. Mr. Pomerol added: «The development of these new technologies represents great leverages for the implementation of tele-expertise and second opinion networks in an effort to improve patient care by accelerating the diagnosis and reducing costs. These are the first results of telepathology and telehaematology networks that we currently operate in Europe. “
CaloPix is a TRIBVN software solution for managing, viewing, analyzing and sharing virtual slides and macroscopic images. This software is a daily tool for that helps laboratory to adopt digital processes. Workflow, security and traceability of data are optimized thanks to integration with information systems of the laboratory and of the hospital.
TeleSlide is a TRIBVN software solution for managing and sharing data and images dedicated to telemedicine and education activities. Patient data are exchanged in a secure way through the web within predefined scenarios of teleexpertise, second opinion, on-watch and remote frozen-section networks.